Auddia Inc. (NASDAQ: AUUD) today spotlighted Influence Healthcare, a healthtech company that leverages artificial intelligence and vertical integration to enable surgeons to lead the adoption of value-based care (VBC) in high-spend surgical specialties. The company also announced its intention to file a Form S-4 with the Securities and Exchange Commission later this week, a key step in the merger process with Thramann Holdings, LLC.
Influence Healthcare is the final subsidiary—alongside LT350 and Voyex—that will join Auddia upon closing of the previously signed definitive merger agreement. The combined entity will operate under the name McCarthy Finney, trading under the ticker MCFN.
The platform is built on a simple premise: physicians deliver the value, so physicians should lead the system. Influence Healthcare organizes surgeons into vertically integrated Value Based Enterprises (VBEs) that contract for bundled case-rate payments in spine, total joints, and other high-spend specialties. These VBEs are supported by advanced AI workflows that automate documentation, coding, episode validation, care-pathway coordination, staffing, supply chain, and logistics, allowing surgeons to focus on clinical care rather than administrative tasks.
Jeff Thramann, M.D., CEO of Auddia and Founder of Influence Healthcare, said: “Healthcare is about a physician and patient entering into a relationship to optimize delivery of the highest quality care. Only the physician has the knowledge, relationship with the patient, and clinical authority to make the many real-time decisions required to deliver the highest quality care at the lowest possible price. Influence Healthcare is aimed at leveraging AI to minimize administrative noise so that physicians and all the other healthcare professionals with hands on patients are empowered to deliver the highest value care.”
Influence Healthcare is designed as a structural alternative to two dominant models: hospital employment, which often reduces physician autonomy and increases administrative overhead, and private-equity rollups, which prioritize financial engineering over clinical leadership. Instead, Influence Healthcare creates surgeon-led enterprises where surgeons retain governance authority, episode-based economics flow to clinicians, facilities participate through aligned partnerships, and AI reduces overhead.
Post-merger, Influence Healthcare will leverage shared AI services from McCarthy Finney to deploy agentic-AI workflows that automate clinical documentation, coding and billing preparation, episode-of-care validation, prior-authorization workflows, care-pathway adherence monitoring, and communication across the episode. These workflows are designed to eliminate administrative layers that have historically required multiple full-time administrative staff per surgeon, contributing to burnout and rising costs.
“AI should not replace physicians, it should replace the administrative friction that prevents physicians from practicing at the top of their license,” Dr. Thramann said. “Our platform gives surgeons the environment they need to deliver a more predictable, coordinated, efficient, and compassionate episode of care.”
The company’s initial focus is on spine and total joint surgery, with plans to expand to additional specialties and markets through physician-led VBEs. For more information about Influence Healthcare, visit www.influencehealthcare.com.
About the Auddia Merger: Auddia entered into a definitive merger agreement on February 17, 2026. The merger contemplates a business combination between Auddia Inc. and Thramann Holdings, LLC, which fully owns LT350, Influence Healthcare, and Voyex. Upon merger completion, Auddia will change its name to McCarthy Finney and trade under the ticker MCFN. For more information about Auddia, visit www.auddia.com.
